A detailed history of Morgan Stanley transactions in Omeros Corp stock. As of the latest transaction made, Morgan Stanley holds 297,926 shares of OMER stock, worth $3.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297,926
Previous 197,351 50.96%
Holding current value
$3.07 Million
Previous $801,000 47.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.54 - $5.47 $356,035 - $550,145
100,575 Added 50.96%
297,926 $1.18 Million
Q2 2024

Oct 17, 2024

SELL
$3.04 - $4.23 $55,315 - $76,969
-18,196 Reduced 8.44%
197,351 $801,000
Q2 2024

Aug 14, 2024

SELL
$3.04 - $4.23 $55,315 - $76,969
-18,196 Reduced 8.44%
197,351 $801,000
Q1 2024

Oct 17, 2024

BUY
$2.88 - $4.89 $52,404 - $88,978
18,196 Added 9.22%
215,547 $743,000
Q1 2024

Aug 16, 2024

SELL
$2.88 - $4.89 $192,551 - $326,935
-66,858 Reduced 23.67%
215,547 $743,000
Q1 2024

May 15, 2024

SELL
$2.88 - $4.89 $192,551 - $326,935
-66,858 Reduced 23.67%
215,547 $743,000
Q4 2023

Aug 16, 2024

BUY
$1.08 - $3.63 $91,858 - $308,746
85,054 Added 43.1%
282,405 $923,000
Q4 2023

Feb 13, 2024

BUY
$1.08 - $3.63 $47,981 - $161,270
44,427 Added 18.67%
282,405 $923,000
Q3 2023

Nov 15, 2023

BUY
$2.81 - $5.69 $43,732 - $88,553
15,563 Added 7.0%
237,978 $694,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $186,414 - $317,114
-41,891 Reduced 15.85%
222,415 $1.21 Million
Q1 2023

May 15, 2023

BUY
$2.48 - $5.22 $164,743 - $346,759
66,429 Added 33.57%
264,306 $1.23 Million
Q4 2022

Feb 14, 2023

SELL
$1.75 - $3.96 $301,957 - $683,286
-172,547 Reduced 46.58%
197,877 $447,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $1.41 Million - $3.4 Million
-455,779 Reduced 55.17%
370,424 $1.17 Million
Q2 2022

Oct 27, 2022

BUY
$1.92 - $6.28 $271,092 - $886,698
141,194 Added 20.61%
826,203 $2.27 Million
Q2 2022

Aug 15, 2022

BUY
$1.92 - $6.28 $271,092 - $886,698
141,194 Added 20.61%
826,203 $2.27 Million
Q1 2022

Oct 27, 2022

SELL
$5.07 - $7.2 $715,853 - $1.02 Million
-141,194 Reduced 17.09%
685,009 $4.12 Million
Q1 2022

May 13, 2022

SELL
$5.07 - $7.2 $1.92 Million - $2.73 Million
-379,682 Reduced 35.66%
685,009 $4.12 Million
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $4.68 Million - $7.05 Million
825,961 Added 345.98%
1,064,691 $6.85 Million
Q3 2021

Nov 15, 2021

BUY
$13.4 - $16.3 $3.2 Million - $3.89 Million
238,730 New
238,730 $3.29 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.